Brief: Lee's Pharmaceutical Reports Qtrly Profit Attributable of HK$2.11 Bln
26/08/2021 11:30
Aug 26 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY PROFIT ATTRIBUTABLE HK$2.11 BILLION VERSUS HK$57.1
MILLION
* RECOMMENDED INTERIM DIVIDEND OF HK$0.030 PER SHARE
* QTRLY REVENUE HK$300.9 MILLION, UP 6.1%
Source text for Eikon: ID:nHKS6J2w5V
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals